Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $200 | $209 | $261 | $246 |
| - Cash | $4 | $6 | $8 | $21 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $197 | $204 | $254 | $227 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$17 | -$25 | -$6 | -$44 |
| % Margin | – | – | – | – |
| Net Income | -$17 | -$11 | -$6 | -$45 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.226 | -0.15 | -0.08 | -0.75 |
| % Growth | -50.9% | -87.5% | 89.3% | – |
| Operating Cash Flow | -$14 | -$18 | -$16 | -$19 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$14 | -$18 | -$16 | -$19 |